Intermediate-risk Non–muscle-invasive Bladder Cancer: Time To Tidy Up the Mess?-Reference-Cited by-同舟云学术

Intermediate-risk Non–muscle-invasive Bladder Cancer: Time To Tidy Up the Mess?

Published:2022-10 Issue:5 Volume:5 Page:517-518
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Soria Francesco,Gontero Paolo

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference8 articles.

1. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur Urol,2022

2. Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology;Flaig;J Natl Compr Cancer Netw,2020

3. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

4. National Institute for Health and Care Excellence. Bladder cancer: diagnosis and management. London, UK: NICE; 2015. https://www.nice.org.uk/guidance/ng2/evidence/full-guideline-pdf-374410.

5. Intermediate-risk non-muscle-invasive bladder cancer: updated consensus definition and management recommendations from the International Bladder Cancer Group;Tan;Eur Urol Oncol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration;European Urology Oncology;2024-06

2. Editorial comment—Risk stratification and management of nonmuscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories;International Journal of Urology;2023-11-15